700 Industrial Park Drive
Alabaster, AL 35007
1-800-227-0651 or 205-663-2494
Fax 1-800-229-1004 or 205-663-0756

OrdersTechnical QuestionsGeneral Information
the phospholipid people

Comparison of
Quality and Binding Analysis
of S1P and DH-S1P

Reprinted from
“Pharmacological characterization of human S1P4 using a novel radioligand, [4,5-3H]-dihydrosphingosine-1-phosphate”
By James Fossetta, Gregory Deno, Waldemar Gonsiorek, Xuedong Fan, Brian Lavey,
Pradip Das, Charles Lunn, Paul J Zavodny, Daniel Lundell, and R William Hipkin.

The British Journal of Pharmacology (2004); 142: 851-860

[Abstract]
[PubMed]


Competition-binding analysis using different commercially available sphingophospholipids.
Membranes (2 µg per well) from Ba/F3-S1P4-42 cells were incubated in binding buffer at room
temperature (as described in Methods) with 4 nM [3H]DH-S1P and the indicated concentrations
of unlabeled DH-S1P (left) or S1P (right). Radioligand binding to the membranes was measured
by WGA-SPA scintillation. Data represent the mean±s.e.m. of triplicate determinations from a
representative experiment (n=2).


Enlarge
1H NMR spectra of Avanti, Sigma, and Biomol S1P and DH-S1P. Samples were dissolved in 1:1
deuterated methanol:deuterated acetic acid. Spectra were measured at 400MHz using either 64
or 96 scans to obtain adequate signal-to-noise ratios. Signals that do not correlate with the
spectra reported by Li et al. (1999) are noted.

Reproduced from
The British Journal of Pharmacology (2004); 142: 851-860
“Pharmacological characterization of human S1P4 using a novel radioligand, [4,5-3H]-dihydrosphingosine-1-phosphate”
By James Fossetta, Gregory Deno, Waldemar Gonsiorek, Xuedong Fan, Brian Lavey,
Pradip Das, Charles Lunn, Paul J Zavodny, Daniel Lundell, and R William Hipkin.

Avanti thanks Nature Publishing Group for kind permission to reproduce these data.

© Avanti Polar Lipids, Inc. All rights reserved.
Terms of Use | Privacy Policy | Comments